نتایج جستجو برای: lipid based formulation

تعداد نتایج: 3151268  

2012
Nathan M Belliveau Jens Huft Paulo JC Lin Sam Chen Alex KK Leung Timothy J Leaver Andre W Wild Justin B Lee Robert J Taylor Ying K Tam Carl L Hansen Pieter R Cullis

Lipid nanoparticles (LNP) are the leading systems for in vivo delivery of small interfering RNA (siRNA) for therapeutic applications. Formulation of LNP siRNA systems requires rapid mixing of solutions containing cationic lipid with solutions containing siRNA. Current formulation procedures employ macroscopic mixing processes to produce systems 70-nm diameter or larger that have variable siRNA ...

Journal: :Peptides 2013
Cynthia F.F. Santos Sérgio H.S. Santos Adaliene V.M. Ferreira Leida M. Botion Robson A.S. Santos Maria Jose Campagnole-Santos

The β-adrenergic blockers and antagonists of the renin-angiotensin system (RAS) are among the drugs that present better results in the control of cardio-metabolic diseases. The aim of the present study was to evaluate the effect of the association of the β-blocker, atenolol, and an oral formulation of Ang-(1-7) on lipid metabolism in spontaneously hypertensive rats (SHR). The main results showe...

The purpose of this study was to optimize a method for the encapsulation of P5 peptide, a new designed peptide containing MHC class I epitopes from rat HER2/neu protein, into liposomes as an approach for breast cancer vaccine formulation. The efficiency of liposomal encapsulation of peptides is generally low and development of an optimized method to increase encapsulation efficiency is a big ch...

Ali Badiee Mahmoud Reza Jaafari, Mercedeh Mansourian Seyed Alireza Mortazavi, Seyed Amir Jalali, Sheida Shariat

Objective(s):Tumor-associated antigen (TAA) subunit-based vaccines constitute promising tools for anticancer immunotherapy. However, a major limitation in the development of such vaccines is the poor immunogenicity of peptides when used alone.The aim of this study was to develop an efficient vaccine delivery system and adjuvant to enhance anti-tumor activity of a synthetic HER2/neu derived pept...

Journal: :iranian journal of pharmaceutical research 0
sheyda shariat department of pharmaceutics, school of pharmacy, shahid beheshti university of medical sciences, tehran, iran ali badiee nanotechnology research center,school of pharmacy, mashhad university of medical sciences, mashhad, iran mahmoud reza jaafari biotechnology research center, nanotechnology research center ,school of pharmacy, mashhad university of medical sciences, mashhad, iran seyed alireza mortazavi department of pharmaceutics, school of pharmacy, shahid beheshti university of medical sciences, tehran, iran

the purpose of this study was to optimize a method for the encapsulation of p5 peptide, a new designed peptide containing mhc class i epitopes from rat her2/neu protein, into liposomes as an approach for breast cancer vaccine formulation. the efficiency of liposomal encapsulation of peptides is generally low and development of an optimized method to increase encapsulation efficiency is a big ch...

Journal: :iranian journal of basic medical sciences 0
sheida shariat department of pharmaceutics, school of pharmacy, shahid beheshti university of medical sciences, tehran, iran ali badiee nanotechnology research center, school of pharmacy, mashhad university of medical sciences, mashhad, iran seyed amir jalali department of immunology, medical school, shahid beheshti university of medical sciences, tehran, iran mercedeh mansourian nanotechnology research center, school of pharmacy, mashhad university of medical sciences, mashhad, iran seyed alireza mortazavi department of pharmaceutics, school of pharmacy, shahid beheshti university of medical sciences, tehran, iran mahmoud reza jaafari biotechnology research center, nanotechnology research center, school of pharmacy, mashhad university of medical sciences, mashhad, iran

objective(s):tumor-associated antigen (taa) subunit-based vaccines constitute promising tools for anticancer immunotherapy. however, a major limitation in the development of such vaccines is the poor immunogenicity of peptides when used alone.the aim of this study was to develop an efficient vaccine delivery system and adjuvant to enhance anti-tumor activity of a synthetic her2/neu derived pept...

Journal: :British journal of anaesthesia 1997
A Doenicke M F Roizen R Hoernecke M Mayer P Ostwald J Foss

We sought to determine if the solvent in the formulation of etomidate is responsible for haemolysis in patients. In a randomized, prospective, double-blind study of 49 patients undergoing otolaryngological surgery, patients received etomidate dissolved in propylene glycol or in lipid emulsion. Concentrations of free haemoglobin and haptoglobin were measured before and for up to 360 min after in...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید